GCG and inflammatory bowel disease: Recognition of the complex mechanisms of IBD pathogenesis and potential therapeutic interventions, including the effects of insulin, IGF-1, GLP-1 and TL1A on inflammation and intestinal microbiota, may contribute to the development of more effective therapeutic strategies for patients with inflammatory bowel diseases.